Should You Buy Clorox Company (The) Stock in 2026?
According to the CirclFi Deep Alpha Valuation Engine, Clorox Company (The) (CLX) is rated as a strong fundamental performer with a QOC score of 7.6/10. Trading at $95.67, our valuation engine evaluates whether the market price reflects the company's underlying earnings power.
The short answer: 2 of 12 CirclFi valuation models project upside for Clorox Company (The) (CLX) at $95.67 — the model consensus leans bearish, with a Quality Score of 7.6/10 and Value-Trap risk of 8/100. The full bull case, bear case, and risk factors are below. Educational analysis, not financial advice.
Investment Thesis
The Bull Case
Target: $166.44 (+74.0% upside)
- According to the CirclFi Quality of Company (QOC) framework, Clorox Company (The)'s rating of 7.6/10 signals strong fundamentals — high-quality businesses tend to compound value more reliably.
- According to the CirclFi Deep Alpha Valuation Engine, the ML Residual Income model targets a fair value of $166.44 (+74.0%), anchoring the bull case with a methodology that provides a differentiated analytical lens.
The Bear Case
Target: $26.46 (-72.3%)
- According to the CirclFi Deep Alpha Valuation Engine, the EROIC Spread model sees the stock as overvalued with a fair value of $26.46 (-72.3%), suggesting that the market price embeds overly optimistic growth assumptions.
- According to the CirclFi Deep Alpha Valuation Engine, model disagreement is high with a +146.3% spread between the most bullish and bearish models, signaling elevated analytical uncertainty.
Peer Benchmarking
The Bottom Line
Our valuation engine sends a clear cautionary signal on Clorox Company (The) at $95.67. 9/12 models flag overvaluation, composite fair value sits at $73.19 (-23.5%), and the risk-reward profile appears unfavorable. Quality at 7.6/10 is the one bright spot, but premium quality at the wrong price can still destroy returns. This is a stock where patience — or avoidance — may be the optimal strategy.
These are quantitative model outputs, not investment recommendations. Clorox Company (The)'s future depends on factors — management execution, competitive dynamics, regulatory changes — that no algorithm can fully capture. See all 13 model estimates →
Frequently Asked Questions
Should I buy CLX stock right now?
Based on CirclFi's multi-model analysis, 2 of 12 models see upside for CLX at $95.67. The models are divided, which means the investment case depends heavily on your assumptions about Clorox Company (The)'s future. This is not a buy recommendation — see our full disclaimer.
What are the biggest risks of investing in Clorox Company (The)?
Key risks include: wide model disagreement (529% spread), signaling high uncertainty; general market and sector-specific risks affecting Specialty Cleaning, Polishing and Sanitation Preparations companies. Always diversify and consult a financial advisor.
How does CLX compare to its competitors?
Among Specialty Cleaning, Polishing and Sanitation Preparations peers, CLX holds a Quality Score of 7.6/10. Comparable companies include ZONE (QOC 5.0). The relative ranking helps investors identify whether CLX offers better fundamental quality than alternatives in the same sector.
Is CLX a good long-term investment?
Long-term investment potential depends on fundamental quality and sustainable competitive advantages. CLX's Quality Score of 7.6/10 is encouraging for long-term holders, indicating consistent profitability, manageable debt, and healthy cash flows. Check our full data page for all 13 model estimates.
What price should I buy CLX at?
CirclFi does not provide target buy prices or price alerts. However, our 12 active models produce fair value estimates ranging from $26.46 to $166.44. At $95.67, the stock trades within the range of model estimates. Many value investors look for a 20-30% margin of safety below intrinsic value before buying.
Want the complete picture?
See all 13 model estimates, confidence scores, and the full valuation table for CLX.
Disclaimer: This article is produced by the CirclFi Valuation Engine using quantitative models and is for educational and informational purposes only. It is not financial advice, a buy/sell recommendation, or a solicitation to trade securities. Past performance is not indicative of future results. All data sourced from SEC EDGAR, FRED, and GDELT. Consult a licensed financial advisor before making investment decisions. Full disclaimer →
Buy with Gumroad